This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1995 Sep;99(3):333-4.

doi: 10.1016/s0002-9343(99)80175-2.

Intermittent cyclic etidronate treatment of postmenopausal osteoporosis

PMID: 7653501
DOI: 10.1016/s0002-9343(99)80175-2

Comment

Intermittent cyclic etidronate treatment of postmenopausal osteoporosis

J L Sternberg. Am J Med. 1995 Sep.

. 1995 Sep;99(3):333-4.

doi: 10.1016/s0002-9343(99)80175-2.

Author

PMID: 7653501
DOI: 10.1016/s0002-9343(99)80175-2

No abstract available

PubMed Disclaimer

Comment on

Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy.
Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnut CH 3rd. Harris ST, et al. Am J Med. 1993 Dec;95(6):557-67. doi: 10.1016/0002-9343(93)90350-x. Am J Med. 1993. PMID: 8259772 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.